Minnesota health systems are dropping masking requirements for patients, staff

Numerous Minnesota well being care methods are stress-free their masking demands in a further move away from procedures proven at the peak of the pandemic three several years in the past.

The most current to announce is Mayo Clinic, which declared in a assertion earlier this week that its program would no for a longer period need masks in “most individual care regions on Mayo Clinic and Mayo Clinic Health Program campuses” setting up April 10. Masking will as a substitute be voluntary, besides in large-chance affected individual configurations. In the assertion, Mayo officers stated they approach to notify higher-threat, immunocompromised patients to have on a mask though at their facilities.

Allina Wellbeing also plans to relieve their masking regulations at its amenities, starting April 18.

“These have been conversations that we have genuinely ongoing to have all through the pandemic,” claimed Mallory Koshiol, Allina Health’s VP of method security and good quality.

What does that necessarily mean? The information, analysis and neighborhood conversation found listed here is funded by donations from individuals. Make a present of any amount of money today to guidance this source for all people.

In October 2022, the wellbeing care process announced that staff members could clear away their masks in non-individual treatment spots, like crack rooms and offices. Koshiol claimed this announcement is section of their “stepwise approach.”

“We do have metrics that we’ll keep on to watch ongoing and must [or] if we require to reinstate [the masking mandate] we undoubtedly will,” she claimed. “Safety is our prime priority. So we will proceed to keep track of and get the job done to function to maintain that. And we know our staff are seeking ahead to observing every single other smiling and resuming some degree of normalcy immediately after lots of, quite a few yrs of sporting masks all the time.”

Those people metrics contain occupational overall health between team and group transmission costs. Koshiol claimed team, individuals and visitors can pick out to mask, and clients and guests can ask for that staff members mask when offering care.

Officials at Hennepin Healthcare stated they also system to make improvements to their masking policies. Starting off April 11, masking by staff will go on in individual-struggling with regions, like exam rooms, remedy parts and front desks, but are no longer essential in other locations, like elevators, cafeterias and convention rooms.

Masking will be optional for individuals and visitors, besides in specified eventualities, the assertion said.

Though most people today have stopped putting on masks in community, it is frequently been demanded in well being treatment configurations because the pandemic commenced three many years ago.

Steering from the Facilities for Sickness Manage and Prevention, unveiled in September 2022, claims “[h]ealthcare amenities might choose to give well-fitting facemasks as a source management possibility for visitors but must enable the use of a mask or respirator with better-level security that is not visibly dirty by persons who chose that selection based mostly on their unique desire.”

But some providers say that wellness care is diverse and should really be looked at in another way.

“There’s a lot of people in hospitals that are not actually there by their personal alternative,” claimed Dr. Jill Foster, who specializes in pediatric infectious illnesses at the College of Minnesota Healthcare Faculty and Masonic Kid’s Medical center. She said they have a good deal of significant-risk people who may perhaps not be shielded from COVID the very same way that several in the normal inhabitants are.

“I believe it will make it tough for the reason that then we are creating the susceptible sufferers be the kinds who have to advocate for by themselves alternatively than institutions advocating in advance for them by environment pointers,” she claimed. “The gain is that folks can dress in a mask themselves and come to feel rather safeguarded. But of system, equally folks wearing a mask is certainly a lot much better.”

Other health and fitness care methods all around the condition have by now altered their masking regulations.

CentraCare, which has amenities across Minnesota, claimed their masking change also went into effect on April 2. The group stated that things associated to COVID-19 — such as employee an infection prices and the selection of clients they ended up dealing with with the virus — arrived into participate in in the final decision.

“While COVID-19 is not more than, it’s adjusted greatly because it initial started off. The health impacts are considerably less serious and mortality costs are much lower,” explained Dr. George Morris, who led CentraCare’s COVID response, in a assertion. “We even now have some protocols in location for personnel masking — and our clients need to go on to mask if they have any respiratory signs and symptoms. We will rely on carefully monitored metrics to information long run selections [sic] similar to masking if our atmosphere changes.”

Essentia Well being, which has facilities in central Minnesota and in the Duluth spot, eased masking limitations on April 3. In their announcement, officers mentioned this “does not apply to Essentia’s extensive-term care/nursing residence facilities or assisted residing facilities, which will proceed to examine masking protocols independently. Hospice workers will stick to the procedures of the amenities they enter.”

Officers at Fairview Wellness Solutions stated they’re talking about their masking policy, but did not have something to announce at this time. 

Why antibiotics may not help patients survive their viral infections: new research

Most individuals who are admitted to hospitals with acute viral infections are offered antibiotics by their medical doctors or well being care providers as a precaution versus bacterial co-infection.

Nevertheless new exploration indicates this observe could not strengthen their survival rates. 

Scientists investigated the effects of antibiotic use on survival in more than 2,100 individuals in a clinic in Norway among the many years 2017 and 2021, Reuters reported. 

‘SILENT PANDEMIC’ WARNING FROM WHO: Germs KILLING Also Several Men and women Owing TO ANTIMICROBIAL RESISTANCE

The researchers uncovered that offering antibiotics to persons with prevalent respiratory infections was not likely to decrease the hazard of demise in 30 days.

At the top of the COVID-19 pandemic, antibiotics have been recommended for all around 70{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} of COVID-19 people in some nations, Reuters also explained.

Why antibiotics may not help patients survive their viral infections: new research

Researchers discovered that providing antibiotics to people today with prevalent respiratory infections was unlikely to lower the risk of death in just 30 days. (iStock)

This potentially has contributed to the scourge of antibiotic-resistant pathogens recognized as superbugs.

The new facts has not been released in a professional medical journal to date.

CDC Issues Notify ABOUT DRUG-RESISTANT Stomach BUG’S Spread

It suggests that there is “a large overuse of antibiotics,” claimed direct author Dr. Magrit Jarlsdatter Hovind from Akershus University Hospital and the University of Oslo, Norway, according to Reuters.

It suggests there is “a large overuse of antibiotics.”

Microbes have develop into resistant to numerous treatment plans, specified the overuse and misuse of antibiotics. 

Scientists think about this advancement a remarkable threat to world-wide wellbeing, provided that the pipeline of substitute therapies in progress is alarmingly sparse, Reuters also mentioned.

Exploration will be introduced subsequent month

The latest analysis is to be offered at upcoming month’s European Congress of Medical Microbiology & Infectious Ailments in Copenhagen.

It concerned people who examined favourable by using nasal or throat swab for viral bacterial infections these as the flu, RSV or COVID-19. 

All those with verified bacterial infections ended up excluded from the evaluation.

In overall, 63{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} of the 2,111 clients received antibiotics for their respiratory bacterial infections throughout their clinic keep. 

The new research involved patients who tested positive via nasal or throat swab for viral infections such as the flu, RSV or COVID-19. 

The new research included patients who tested favourable by way of nasal or throat swab for viral infections these types of as the flu, RSV or COVID-19.  (iStock)

Total, 168 people died within just 30 times — of which only 22 experienced not been recommended antibiotics.

Just after accounting for variables these types of as sexual intercourse, age, severity of illness and underlying diseases among the the patients, the researchers identified these recommended antibiotics throughout their healthcare facility remain have been 2 times as probably to die inside 30 times than those people not provided antibiotics.

“Medical professionals have to dare to not give antibiotics, alternatively of doubting and giving antibiotics just in situation.”

Equally the sicker individuals and individuals with extra underlying illnesses have been extra most likely to get antibiotics and to die, the investigation staff mentioned.

EYE Fall BACTERIAL CONTAMINATION ‘COULD HAVE Happened ANYWHERE’ — Here is HOW TO Shield Towards IT 

Other components this sort of as patients’ cigarette smoking position could have also played a purpose, they stated.

“Medical practitioners have to dare to not give antibiotics, instead of doubting and providing antibiotics just in case,” Hovind explained, in accordance to Reuters.

Should patients admitted to the hospital with common respiratory infections be treated with antibiotics? A new study is seeking to determine the answer.

Need to people admitted to the medical center with widespread respiratory infections be addressed with antibiotics? A new research is searching for to ascertain the respond to. (iStock)

There are limits of a retrospective research this sort of as this 1.

It is why a clinical demo, which Hovind and colleagues a short while ago initiated, is wanted to decide no matter whether patients admitted to the medical center with popular respiratory infections should really be addressed with antibiotics, she claimed, as Reuters documented.

Tackling the shortages of antibiotics

In the meantime, in late January 2023, a team of European individual and client groups told the European Union’s drug regulator that it wants to do far more to deal with shortages of some widely used antibiotics in the region, according to a letter despatched and reviewed by Reuters.

The letter to the European Medicines Company (EMA) comes as antibiotics, like amoxicillin, have been in small offer given that past Oct, as Reuters noted.

There has been a spike in demand for certain drugs linked to the resurgence of respiratory infections after two years of COVID restrictions, said Reuters.

There has been a spike in demand from customers for specific medication linked to the resurgence of respiratory bacterial infections following two decades of COVID constraints, stated Reuters. (iStock)

The letter mentioned measures like substituting amoxicillin with other antibiotics have squeezed provide of some other medications — and that the latest actions in place to offer with the shortages have not contained the crisis.

There has been a spike in desire for selected medicine joined to the resurgence of respiratory infections following two several years of COVID restrictions, putting further force on world supplies. 

At the peak of the COVID-19 pandemic, drugmakers minimize output. 

Drugmakers also cut output when demand from customers dipped at the height of the pandemic.

But the letter highlighted escalating problems about prolonged shortages in the area even as the wintertime will come to an end.

Click Below TO GET THE FOX Information App

In yet another modern study on a connected subject matter, little ones who contracted reduce respiratory tract infection (LRTI) at two decades of age or younger had been discovered to be far more likely to die prematurely from that identical problem as adults.

These sorts of infections were being joined to a person-fifth of the fatalities.

Click In this article TO Indicator UP FOR OUR Wellbeing Newsletter

The examine was conducted by a team of London scientists and led by Dr. James Peter Allinson of the Countrywide Heart and Lung Institute at Imperial Faculty London. It was printed in The Lancet in early March. 

The 8-10 years examine analyzed info from the Healthcare Exploration Council Nationwide Study of Health and fitness and Enhancement, which followed 3,589 contributors in England, Scotland and Wales all born in March 1946. 

Melissa Rudy of Fox Information Electronic, as effectively as Reuters, contributed reporting to this report.

Transgender patients face discrimination during health care visits

One trans woman recalled a doctor calling her “it.” A nonbinary person was grilled about their use of “they/them” pronouns during an ultrasound. A trans-masculine person moved out of Tennessee, fearing they would lose access to hormone therapy as legislators passed bills restricting gender-affirming care.

Transgender Americans often face subtle discrimination, outright hostility and ill-informed medical professionals in their interactions with the health-care system, according to a poll by The Washington Post and KFF, a nonprofit focused on national health issues.

Challenges arise during routine medical visits as well as when transgender people seek hormone therapy and other forms of gender-affirming care.

Nearly half (47 percent) of trans adults say the health-care providers they have come in contact with know “not too much” or “nothing at all” about providing health care to trans people. Just 10 percent say the health-care providers they have come in contact with know “a lot” about caring for trans people. About 4 in 10 (37 percent) trans adults say it is “somewhat” or “very” difficult to find a health-care provider who treats them with dignity and respect; while about a quarter (24 percent) of cisgender adults say the same. Just over half (53 percent) of trans adults say it is easy to find health care they can afford, less than the 63 percent of cisgender adults who say the same.

Activists say a welcoming health-care system would include affordable access to gender-affirming care from counseling to surgery. Good care also includes professionals treating transgender people with respect, using their preferred pronouns and not being quick to blame hormone treatment for unrelated medical problems.

About 3 in 10 trans adults say they have had to teach a doctor or other health-care provider about trans people so they could get appropriate care, had a doctor or other health-care provider refuse to acknowledge their preferred gender identity and instead refer to their sex assigned at birth, or been asked unnecessary or invasive questions about their gender identity unrelated to the medical reason for their visit. About 1 in 6 trans adults say they have had a doctor or other health-care provider refuse to provide them with gender-affirming care, such as hormone treatments.

The Post-KFF poll is the largest nongovernmental survey of U.S. trans adults to rely on random sampling methods. It builds on a body of research that has often demonstrated poor access to health care for transgender people but with limited data.

“LGBTQ+ people experience high levels of stigma and discrimination and victimization that persists across the lifetime, and this new work amplifies that,” said Lindsey Dawson, director of LGBTQ Health Policy at KFF.

“To have your gender affirmed and to be in an inclusive environment where you have to be quite vulnerable about gender identity can be quite meaningful,” Dawson said. “To have negative experiences might dissuade somebody from accessing health care in the future.”

As Republican state lawmakers mobilize to restrict access to gender-affirming care for children — and in some cases, adults — the poll offers a reminder of the basic struggles transgender adults face in medical environments.

The poll finds trans people’s ease of access to health-care providers who treat them with dignity and respect is not significantly different in states that former president Donald Trump won compared with states President Biden won. The survey also finds that trans adults in urban areas are more likely to report having to educate health-care professionals (38 percent) than those in suburban/rural areas (23 percent) — challenging perceptions that more liberal areas are havens for tolerance and inclusivity.

In follow-up interviews, five transgender and nonbinary Americans who responded to the poll elaborated on their experiences:

Corey Brooks (they/them)

25, Pittsburgh

Even the name of the place Corey Brooks frequented for routine medical care — Magee-Womens Hospital — felt alienating.

Patients donned pink gowns. Cutouts of pink bras were plastered on the walls. A sign urged patients to “fight like a girl.”

“Things like that are just incredibly disorienting for someone going into those spaces who is always being reminded, hey, this wasn’t designed for you,” Brooks said. “You’re not really sure if you should disclose to these people that you’re trans or not.”

Brooks identifies as nonbinary and transgender, but as someone who was assigned female at birth, they share similar health needs as cisgender women for gynecologic care and screenings for chest health as they age.

Brooks was used to uncomfortable visits to the doctor, based on their college experiences when university health services staff peppered them with questions about birth control and sexual activity, assuming they were a cisgender heterosexual woman. They wrote their senior thesis on health access issues for transgender people and avoided the doctor for a few years after graduation.

The worst experience came while undergoing an ultrasound on their chest at the women’s hospital in Pittsburgh. The doctor paused and stared at Brooks’s medical file, spotting a note that they use they/them pronouns.

“What does that even mean?” Brooks recalled the doctor asking in a tone dripping with hostility rather than curiosity.

“As a trans person, that’s unfortunately not uncommon where you’re expected to provide all of this education for your providers,” Brooks said. “You wouldn’t expect a patient who is diagnosed with diabetes to have to educate their doctor on what diabetes is.”

Suzanne Rathburn (she/her)

70, Weed, Calif.

In the 1980s, a psychiatrist pushed his chair away from his desk and abruptly ended a meeting after Suzanne Rathburn explained she was trans. In 2012, a Veterans Affairs doctor referred to her as “it.”

In hundreds of medical visits over decades of navigating gender-affirming care and a rare genetic disease, Rathburn said she’s only had a few doctors she considers “good.”

As she began her transition in the 1980s after leaving the Air Force, Rathburn turned to the library to learn more about gender dysphoria and to find a therapist. She received a vaginoplasty. At the Oakland VA where she underwent hormone therapy, Rathburn said just one of the doctors treated her with respect, while others were dismissive of her medical needs or made negative comments about her gender identity — despite being in the LGBT-friendly San Francisco Bay Area.

Fed up after repeated indignities, Rathburn filed a discrimination complaint against another VA hospital that declined to perform a Pap test after several years of her requests. She said the VA eventually referred her to a doctor outside the system, and her complaint remained unresolved.

It wasn’t until she moved to rural Weed near the Oregon border in 2011 at age 59 that Rathburn experienced some of the best medical care of her life. A medical practice she visited near Medford, Ore., changed its intake forms when she pointed out gender questions were binary. A doctor in the nearby town of Mount Shasta, Calif., treated her trans identity as no big deal and spent time researching her genetic disease. Her therapist, also in Mount Shasta, specializes in supporting trans patients.

“I don’t have to explain it to her,” Rathburn said. “We talked about stuff I haven’t talked about with other therapists or to the psychiatrists I’ve had over 20 years.”

Hans Dirkmaat (they/he)

29, Longmont, Colo.

Hans Dirkmaat knew the nurse practitioner was ill-suited to care for transgender people when they had to explain what top surgery was.

During the primary-care visit, the provider marveled at why someone would want to remove their breasts. She asked, “When are you going to get a penis?”

Another medical professional in the room mouthed, “I’m sorry.”

Dirkmaat, who identifies as trans-masculine and nonbinary, didn’t have many choices for medical care that were in their insurance provider network when they lived in Nashville. They hoped the provider would have been more sensitive because she had mentioned having a lesbian daughter during their first appointment.

But tolerance for gay people does not mean a medical provider is attuned to the health-care needs of trans people. Transgender people weigh the risks and benefits of different aspects of gender-affirming medical care, and most have not received hormone therapy or transition-related surgeries.

Dirkmaat was wary of taking testosterone because of a heightened risk of cardiovascular complications. Their mother had died of heart disease at 41.

But that same nurse practitioner declined to prescribe medication to treat their high cholesterol because it could create pregnancy complications. The fact that Dirkmaat is married to a cisgender woman and has no plans to have children did not sway the provider. She said she would only authorize the pills if Dirkmaat were to undergo testosterone treatment.

“It’s very frustrating,” Dirkmaat said. “Like I can’t make decisions for me.”

The climate for transgender people in Nashville was starting to feel more unsafe, they said. The clinic specializing in transgender care where they received chest masculinization surgery became a magnet for right-wing protests, forcing the clinic to close on some days to protect patients. They drew more disgusted looks on the streets.

Tennessee GOP lawmakers joined the vanguard of a national movement to restrict care for transgender people, passing legislation to ban gender-affirming care for minors. Activists fear care for adults is next, noting legislation introduced to prohibit the state Medicaid program from working with insurers that cover gender-affirming care.

As Dirkmaat weighed whether to take hormones, they feared such therapy could be banned next.

So they moved to a suburb of Boulder, Colo., where a doctor who specializes in hormone therapy and its effects on the cardiovascular system is just an hour drive away.

Ezekiel Scott (he/they)

31, Columbus, Ohio

When Ezekiel Scott left Minnesota to attend college in Ohio last year, he brought six months’ worth of hormone medication just in case he ran into trouble resuming care. It wasn’t enough.

Administrators at Ohio State University assured Scott, who identifies as transgender and nonbinary, that hormone therapy would be covered under student health insurance. But first he needed to reestablish care with a doctor — and that proved to be a challenge.

He didn’t want to go to just any doctor, but one familiar with treating transgender patients. He had had negative experiences with doctors who were quick to blame the hormone therapy for mundane medical conditions, including one who suggested ending it to address a rash on his arm.

“That’s the first thing we’re going to try? Not like, I don’t know, a skin cream?” Scott said.

The hormones were essential to feeling comfortable in his own skin and affirming his gender identity, but the treatment was cast as cosmetic and unnecessary. “It’s like being told to stop having your own face,” he said.

It took four months to get an appointment at a university health clinic. After obtaining authorization to receive testosterone, a national shortage of the intramuscular injections further delayed his access to treatment as he exhausted his previous supply.

For several months, he had to ration weekly hormone injections that helped him develop facial hair and a deeper voice in line with his gender identity. And because he had had his ovaries removed, the absence of natural hormones risked his heart health.

His depression and anxiety grew worse, and he experienced suicidal ideations. Medication management for ADHD, once balanced with the hormone therapy, became complicated. He experienced hot flashes, an apparent result of early menopause caused by hormones not coming in properly.

Months later, he found a walk-in clinic recommended by a nonbinary friend. He got hormones that same day, eight months after he moved. His mental health improved, he could focus in school again, and the hot flashes ended.

“All of it is back in balance,” Scott said.

Richael Faithful (they/them)

37, Washington, D.C.

Richael Faithful is no stranger to cringeworthy moments during visits to the doctor.

Staff at some offices would misgender them. The first dermatologist they saw appeared nervous and avoided eye contact after Faithful disclosed being trans. One lung specialist they saw for breathing issues who seemed well-meaning shared a story about knowing “a transgender.”

“Once folks have bad experiences, it’s really hard to trust the health-care system again,” said Faithful, a D.C. resident who identifies as nonbinary and trans-masculine. “But I do want other trans folks and other cis folks to know there are good providers out there providing high-quality care.”

Faithful does not identify as a woman but is not transitioning to be a man either. For them, gender-affirming care means presenting more masculine to the world.

Faithful considers themselves part of the top 1 percent in being able to access gender-affirming care because they have the financial means and emotional support network to do so.

Faithful sought hormone therapy through a nurse practitioner at a medical concierge service with a reputation for being trans friendly and where membership costs $300 a year. They pay $265 every month and a half for hormones. They were able to travel with their partner to Florida for two weeks to undergo chest reconstruction surgery from a well-known plastic surgeon who does not accept health insurance and charges $15,000, paid in advance.

The staff at another dermatology practice where Faithful received acne treatment used the correct pronouns and showed a nuanced understanding of the relationship between hormone treatment and acne.

Faithful said they could afford these services as a consultant for social justice organizations who receives health insurance through their partner’s plan — while other Black transgender people living in the poorest parts of the city struggle to access basic gender-affirming care.

“My stress level is just kind of lower because I notice I’m not navigating even seemingly small things that just are distracting or annoying when they continue to happen,” Faithful said.

Scott Clement and Emily Guskin contributed to this report.

Feds Move to Rein In Prior Authorization, a System That Harms and Frustrates Patients

When Paula Chestnut needed hip replacement surgery last year, a pre-operative X-ray found irregularities in her chest.

As a smoker for 40 years, Chestnut was at high risk for lung cancer. A specialist in Los Angeles recommended the 67-year-old undergo an MRI, a high-resolution image that could help spot the disease.

But her MRI appointment kept getting canceled, Chestnut’s son, Jaron Roux, told KHN. First, it was scheduled at the wrong hospital. Next, the provider wasn’t available. The ultimate roadblock she faced, Roux said, arrived when Chestnut’s health insurer deemed the MRI medically unnecessary and would not authorize the visit.

“On at least four or five occasions, she called me up, hysterical,” Roux said.

Months later, Chestnut, struggling to breathe, was rushed to the emergency room. A tumor in her chest had become so large that it was pressing against her windpipe. Doctors started a regimen of chemotherapy, but it was too late. Despite treatment, she died in the hospital within six weeks of being admitted.

Though Roux doesn’t fully blame the health insurer for his mother’s death, “it was a contributing factor,” he said. “It limited her options.”

Few things about the American health care system infuriate patients and doctors more than prior authorization, a common tool whose use by insurers has exploded in recent years.

Prior authorization, or pre-certification, was designed decades ago to prevent doctors from ordering expensive tests or procedures that are not indicated or needed, with the aim of delivering cost-effective care.

Originally focused on the costliest types of care, such as cancer treatment, insurers now commonly require prior authorization for many mundane medical encounters, including basic imaging and prescription refills. In a 2021 survey conducted by the American Medical Association, 40{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} of physicians said they have staffers who work exclusively on prior authorization.

So today, instead of providing a guardrail against useless, expensive treatment, pre-authorization prevents patients from getting the vital care they need, researchers and doctors say.

“The prior authorization system should be completely done away with in physicians’ offices,” said Dr. Shikha Jain, a Chicago hematologist-oncologist. “It’s really devastating, these unnecessary delays.”

In December, the federal government proposed several changes that would force health plans, including Medicaid, Medicare Advantage, and federal Affordable Care Act marketplace plans, to speed up prior authorization decisions and provide more information about the reasons for denials. Starting in 2026, it would require plans to respond to a standard prior authorization request within seven days, typically, instead of the current 14, and within 72 hours for urgent requests. The proposed rule was scheduled to be open for public comment through March 13.

Although groups like AHIP, an industry trade group formerly called America’s Health Insurance Plans, and the American Medical Association, which represents more than 250,000 physicians in the United States, have expressed support for the proposed changes, some doctors feel they don’t go far enough.

“Seven days is still way too long,” said Dr. Julie Kanter, a hematologist in Birmingham, Alabama, whose sickle cell patients can’t delay care when they arrive at the hospital showing signs of stroke. “We need to move very quickly. We have to make decisions.”

Meanwhile, some states have passed their own laws governing the process. In Oregon, for example, health insurers must respond to nonemergency prior authorization requests within two business days. In Michigan, insurers must report annual prior authorization data, including the number of requests denied and appeals received. Other states have adopted or are considering similar legislation, while in many places insurers regularly take four to six weeks for non-urgent appeals.

Waiting for health insurers to authorize care comes with consequences for patients, various studies show. It has led to delays in cancer care in Pennsylvania, meant sick children in Colorado were more likely to be hospitalized, and blocked low-income patients across the country from getting treatment for opioid addiction.

In some cases, care has been denied and never obtained. In others, prior authorization proved a potent but indirect deterrent, as few patients have the fortitude, time, or resources to navigate what can be a labyrinthine process of denials and appeals. They simply gave up, because fighting denials often requires patients to spend hours on the phone and computer to submit multiple forms.

Erin Conlisk, a social science researcher for the University of California-Riverside, estimated she spent dozens of hours last summer trying to obtain prior authorization for a 6-mile round-trip ambulance ride to get her mother to a clinic in San Diego.

Her 81-year-old mother has rheumatoid arthritis and has had trouble sitting up, walking, or standing without help after she damaged a tendon in her pelvis last year.

Conlisk thought her mom’s case was clear-cut, especially since they had successfully scheduled an ambulance transport a few weeks earlier to the same clinic. But the ambulance didn’t show on the day Conlisk was told it would. No one notified them the ride hadn’t been pre-authorized.

The time it takes to juggle a prior authorization request can also perpetuate racial disparities and disproportionately affect those with lower-paying, hourly jobs, said Dr. Kathleen McManus, a physician-scientist at the University of Virginia.

“When people ask for an example of structural racism in medicine, this is one that I give them,” McManus said. “It’s baked into the system.”

Research that McManus and her colleagues published in 2020 found that federal Affordable Care Act marketplace insurance plans in the South were 16 times more likely to require prior authorization for HIV prevention drugs than those in the Northeast. The reason for these regional disparities is unknown. But she said that because more than half the nation’s Black population lives in the South, they’d be the patients more likely to face this barrier.

Many of the denied claims are reversed if a patient appeals, according to the federal government. New data specific to Medicare Advantage plans found 82{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} of appeals resulted in fully or partially overturning the initial prior authorization denial, according to KFF.

It’s not just patients who are confused and frustrated by the process. Doctors said they find the system convoluted and time-consuming, and feel as if their expertise is being challenged.

“I lose hours of time that I really don’t have to argue … with someone who doesn’t even really know what I’m talking about,” said Kanter, the hematologist in Birmingham. “The people who are making these decisions are rarely in your field of medicine.”

Occasionally, she said, it’s more efficient to send patients to the emergency room than it is to negotiate with their insurance plan to pre-authorize imaging or tests. But emergency care costs both the insurer and the patient more.

“It’s a terrible system,” she said.

A KFF analysis of 2021 claims data found that 9{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} of all in-network denials by Affordable Care Act plans on the federal exchange, healthcare.gov, were attributed to lack of prior authorization or referrals, but some companies are more likely to deny a claim for these reasons than others. In Texas, for example, the analysis found 22{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} of all denials made by Blue Cross and Blue Shield of Texas and 24{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} of all denials made by Celtic Insurance Co. were based on lack of prior authorization.

Facing scrutiny, some insurers are revising their prior authorization policies. UnitedHealthcare has cut the number of prior authorizations in half in recent years by eliminating the need for patients to obtain permission for some diagnostic procedures, like MRIs and CT scans, said company spokesperson Heather Soules. Health insurers have also adopted artificial intelligence technology to speed up prior authorization decisions.

Meanwhile, most patients have no means of avoiding the burdensome process that has become a defining feature of American health care. But even those who have the time and energy to fight back may not get the outcome they hoped for.

When the ambulance never showed in July, Conlisk and her mother’s caregiver decided to drive the patient to the clinic in the caregiver’s car.

“She almost fell outside the office,” said Conlisk, who needed the assistance of five bystanders to move her mother safely into the clinic.

When her mother needed an ambulance for another appointment in September, Conlisk vowed to spend only one hour a day, for two weeks leading up to the clinic visit, working to get prior authorization. Her efforts were unsuccessful. Once again, her mother’s caregiver drove her to the clinic himself.

Do you have an experience with prior authorization you’d like to share? Click here to tell your story.

Related Topics

Contact Us

Submit a Story Tip

Former CEO Of Medical Device Company Indicted For Creating And Selling A Fake Medical Component That Was Implanted Into Patients | USAO-SDNY

Damian Williams, the United States Attorney for the Southern District of New York, Michael J. Driscoll, the Assistant Director in Charge of the New York Field Office of the Federal Bureau of Investigation (“FBI”), and Fernando P. McMillan, the Special Agent in Charge of the New York Field Office of the U.S. Food and Drug Administration – Office of Criminal Investigations (“FDA-OIC”), announced today the filing of a two-count Indictment (the “Indictment”) charging Laura PERRYMAN, the former Chief Executive Officer (“CEO”) of STIMWAVE LLC, a Florida-based medical device company, in connection with a scheme to create and sell a non-functioning dummy medical device for implantation into patients suffering from chronic pain, resulting in millions of dollars in losses to federal healthcare programs.  PERRYMAN was arrested this morning in Delray Beach, Florida, and will be presented later today in the United States District Court for the Southern District of Florida.  

In addition, Mr. Williams announced the unsealing of a non-prosecution agreement (the “Agreement”) with STIMWAVE LLC (“STIMWAVE”), which filed for bankruptcy on June 15, 2022.  The Agreement was entered into on October 29, 2022, and was sealed by the United States Bankruptcy Court for the District of Delaware, pending the Government’s ongoing investigation.  Under the terms of the Agreement, STIMWAVE has accepted responsibility for its conduct by, among other things: (i) making admissions and stipulating to the accuracy of an extensive Statement of Facts; (ii) paying a $10,000,000 monetary penalty; and (iii) maintaining an adequate compliance program, to include employing a Chief Compliance Officer and holding regular compliance committee meetings.  STIMWAVE is also required to cooperate fully with the Government.  STIMWAVE’s obligations under the Agreement will continue for a period of three years from the date of execution of the Agreement.   

The U.S. Attorney’s Office also unsealed a civil fraud lawsuit filed against STIMWAVE under the False Claims Act (“FCA”), and the parties’ settlement of that suit (the “FCA Settlement”).  The settlement has been submitted to United States District Judge George B. Daniels for approval.  In connection with the FCA Settlement, STIMWAVE admitted and accepted responsibility for conduct alleged in the Government’s civil complaint and agreed to pay $8,600,000 to the United States.  This payment will be credited towards the $10,000,000 monetary penalty discussed above.  The civil complaint also brings claims against PERRYMAN under the FCA, which are pending.

U.S. Attorney Damian Williams said: “As alleged, at the direction of its founder and CEO Laura Perryman, Stimwave created a dummy medical device component — made entirely of plastic — designed to be implanted in patients for the sole purpose of causing doctors to unwittingly bill Medicare and private insurance companies more than $16,000 for each implantation of the piece of plastic.  The defendant and Stimwave did this so that they could charge medical providers many thousands of dollars for purchasing their medical device.  Our Office will continue to do everything in its power to bring to justice anyone responsible for perpetuating health care fraud, which in this case led to patients being used as nothing more than tools for financial enrichment.”

FBI Assistant Director Michael J. Driscoll said: “Ms. Perryman, as the Chief Executive Officer of Stimwave, allegedly led a scheme to sell medical devices that contained a non-functioning component that doctors unwittingly implanted into patients suffering from chronic pain.  As a result of her illegal actions, not only did patients undergo unnecessary implanting procedures, but Medicare was defrauded of millions of dollars.  Today’s action demonstrates the FBI’s continuing commitment to protect Medicare and other government programs from financial fraud and abuse.”

FDA-OIC Special Agent in Charge Fernando P. McMillan said: “Individuals and companies that manufacture and distribute medical devices with non-functional components put the health of patients at significant risk.  We will continue to pursue and bring to justice those who jeopardize the health of their patients and of the public.”

According to the documents unsealed today in Manhattan federal court and the United States Bankruptcy Court for the District of Delaware:[1]

STIMWAVE was a medical device company that manufactured and distributed implantable neurostimulation devices designed to treat intractable, chronic pain.  Founded in 2010 by PERRYMAN and others, STIMWAVE was headquartered in Pompano Beach, Florida.

STIMWAVE was founded on the premise that its products would provide non-opioid alternatives to chronic pain management.  As the founder and CEO of STIMWAVE, PERRYMAN oversaw the design of the StimQ PNS System (the “Device”), a neurostimulator medical device that treated chronic pain by producing electrical currents to target peripheral nerves outside the spinal cord.  From at least in or about 2017 up to and including her termination in or about 2019, PERRYMAN, as STIMWAVE’s CEO, engaged in a multi-year scheme (the “Scheme”) to design, create, manufacture, and market an inert, non-functioning component of the Device — called the “White Stylet” — that served no medical purpose but was included with the Device through in or about 2020 in order to make the product financially viable for doctors to purchase. 

When STIMWAVE originally brought the Device to market in or about 2017, it contained three primary components: (i) an implantable electrode array (the “Lead”) that stimulated the nerve; (ii) an externally worn battery that sat outside the body and wirelessly provided power to the Lead through the patient’s skin (the “Battery”); and (iii) a separate implantable receiver measuring approximately 23 centimeters in length with a distinctive pink handle — called the “Pink Stylet.”  The Pink Stylet contained copper and, unlike the White Stylet, functioned as a receiver to transmit energy from the Battery to the Lead.

STIMWAVE sold the Device to doctors and medical providers for over approximately $16,000.  Medical insurance providers, including Medicare, would reimburse medical practitioners for implanting the Device into patients through two separate reimbursement codes, one for implantation of the Lead and a second for implantation of the Pink Stylet.  The billing code for implanting the Lead provided for reimbursement at a rate of between approximately $4,000 and $6,000, while the billing code for implanting a receiver, like the Pink Stylet, provided for reimbursement at a rate of between approximately $16,000 and $18,000.

Soon after the Device was released, physicians informed STIMWAVE that they were having trouble implanting the Pink Stylet in certain patients because the Pink Stylet was too long.  STIMWAVE and PERRYMAN knew that the Pink Stylet could not be cut or trimmed to shorten it without interfering with the functionality of the Pink Stylet as a receiver, and without a receiver component for doctors to implant and seek reimbursement for, doctors would incur a substantial financial loss with every purchase of the Device, thereby making it more difficult for STIMWAVE to sell the Device to doctors and medical providers at the approximately $16,000 price.

However, STIMWAVE — at the direction of PERRYMAN — did not lower the price of the Device so that its cost to doctors and medical providers could be covered by reimbursement for the implantation of only the Lead, nor did PERRYMAN recommend that doctors not implant the Device or its receiver component in cases where the Pink Stylet could not fit comfortably.  Instead, PERRYMAN directed that STIMWAVE create the White Stylet — a dummy component made entirely of plastic that served no medical purpose but which STIMWAVE misrepresented to doctors as a customizable receiver alternative to the Pink Stylet.  The White Stylet could be cut to size by the doctor for use in smaller anatomical spaces and was created solely so that doctors and medical providers would continue to purchase the Device for use in those scenarios and continue to bill for the implantation of a receiver component.  To perpetuate the lie that the White Stylet was functional, PERRYMAN oversaw training that suggested to doctors that the White Stylet was a “receiver,” when, in fact, it was made entirely of plastic, contained no copper, and therefore had no conductivity.  In addition, PERRYMAN directed other STIMWAVE employees to vouch for the efficacy of the White Stylet, when she knew that the White Stylet was actually non-functional.

As a result of these misrepresentations regarding the functionality of the White Stylet, PERRYMAN caused doctors and medical providers to unwittingly implant the non-functional White Stylet into patients and submit fraudulent reimbursement claims for implantation of the White Stylet to Medicare, resulting in millions of dollars in losses to the federal government.

On June 15, 2022, STIMWAVE filed for bankruptcy in Delaware under Chapter 11 of the Bankruptcy Code, through which it sold substantially all of its assets to a third-party through an auction.

*                *                *

PERRYMAN, 54, of Delray Beach, Florida, has been charged with one count of conspiracy to commit wire fraud and health care fraud, which carries a maximum potential sentence of 20 years in prison, and one count of health care fraud, which carries a maximum potential sentence of 10 years in prison. 

The maximum potential sentences are prescribed by Congress and are provided here for informational purposes only, as any sentencing of the defendant will be determined by the judge. 

Mr. Williams praised the investigative work of the FBI and thanked the FDA for its assistance.

The criminal case is being handled by the Complex Frauds and Cybercrime Unit of the Office’s Criminal Division.  Assistant U.S. Attorneys Louis A. Pellegrino, Jacob M. Bergman, and Mónica P. Folch are in charge of the prosecution.  The civil case against STIMWAVE and PERRYMAN is being handled by the Civil Frauds Unit of the Office’s Civil Division.  Assistant U.S. Attorneys Jacob M. Bergman and Mónica P. Folch are in charge of the civil case.

The charges contained in the Indictment are merely accusations, and the defendant is presumed innocent unless and until proven guilty.


[1] As the introductory phrase signifies, the entirety of the text of the Indictment constitutes only allegations, and every fact described herein should be treated as an allegation.

Former Biotech CEO Arrested for Implanting Phony Medical Devices in Patients

Image by Getty / Futurism

New bad guy alert: according to an FBI indictment, Florida woman Laura Perryman, the former CEO of a health-tech company called Stimwave, was arrested on Thursday “in connection with a scheme to create and sell a non-functioning dummy medical device for implantation into patients suffering from chronic pain,” Vice reports, accusations that Perryman’s lawyer has since denied.

In other words, the FBI is alleging that Perryman knowingly created and sold fake medical implants that were entirely made out of plastic to medical systems and their patients, under the guise that the devices would be able to ease chronic pain.

The news comes after Stimwave filed for bankruptcy last year, and has previously agreed to pay $10 million over a related whistleblower lawsuit, Reuters reports.

Perryman and Stimwave, which according to Engadget received FDA approval for an early version of its implant back in 2014, actually sold two different rodlike implants, which they claimed could both alleviate pain by way of electrical signaling — no addictive painkillers required.

“From the patient perspective, they definitely want pain-relief alternatives that are not opioids,” Perryman told Engadget in an interview back in 2017, “but taking the leap from opioid to surgery and a tiny battery inside your body sounds daunting.”

Perryman’s firm even had some big-name celebrity sponsors, notably football Hall of Famer Joe Montana.

“If this was another major surgical process, I probably would’ve said no,” Montana told CBS — which did a whole segment documenting Montana’s experience undergoing the “state of the art” procedure — in 2019. “But I really think this is going to be the answer to my knee and I’m looking forward to an hour or two from now when I get done.”

“It’s just like anything,” Montana continued. “What’s good for me is not always what’s good for you, right? Everyone should do their own research on it. But I wouldn’t be doing this and moving forward with it if I didn’t believe it wasn’t something that could help people.”

But as Vice explains, their first product, a nine-inch-long, computer-chip-embedded device dubbed the “Pink Stylet,” was often too large for doctors to comfortably implant into some patients. But rather than turn down any potential sales, the FBI alleges that Perryman and Stimwave instead came out with the “White Stylet,”  which they claimed was just a smaller and more comfortable — but equally as effective — version.

It’s unclear which version of the device Montana received — which, as it turns out, could’ve made a huge difference.

Because the White Stylet was nothing more than a piece of plastic, according to the FBI’s indictment. No computer chip, no electrical signaling. Just plastic.

And they weren’t cheap, either — according to the FBI, Perryman and Stimwave sold the phony plastic tubes at over $16,000 a pop.

“As alleged, at the direction of its founder and CEO Laura Perryman, Stimwave created a dummy medical device component — made entirely of plastic — designed to be implanted in patients for the sole purpose of causing doctors to unwittingly bill Medicare and private insurance companies more than $16,000 for each implantation of the piece of plastic,” US Attorney Damian Williams said in the indictment.

“The defendant and Stimwave did this,” he added, “so that they could charge medical providers many thousands of dollars for purchasing their medical device.”

Meanwhile, Perryman’s lawyer Jared Dwyer of Greenberg Traurig called the allegations “wrong, starting with the description of the neurostimulator that Laura invented” in a statement to Futurism.

“Every piece of that system had a function and was necessary depending on the patient’s needs,” he added. “And, at the end of the day, the components that were used were up to the doctors. This is a case about a company looking for a quick way out that decided to scapegoat the founder.”

Per the indictment, Perryman has officially been charged with “one count of conspiracy to commit wire fraud and health care fraud, which carries a maximum potential sentence of 20 years in prison, and one count of health care fraud, which carries a maximum potential sentence of ten years in prison.”

As the FBI notes in the indictment, these are still only accusations, and Perryman has yet to go to trial.

“Laura looks forwarded to addressing these allegations in court,” Dwyer told Futurism.

But given the evidence, things aren’t looking great for her. Besides, you involve Joe Montana in your scam, and you involve the fury of the American public.

“Our Office will continue to do everything in its power to bring to justice anyone responsible for perpetuating health care fraud,” said Williams, “which in this case led to patients being used as nothing more than tools for financial enrichment.”

Futurism has reached out to Stimwave for comment.

READ MORE: People Were Unwittingly Implanted With Fake Devices in Medical Scam, FBI Alleges [Vice]

More on medical scammers: Elizabeth Holmes Hopes Her New Baby Will Keep Her out of Prison